Form 4: FibroGen CFO Juan Graham Reports Stock Disposals for Tax Obligations
SEC Form 4 Filing
Juan Graham, CFO of FibroGen, disposed of shares to cover tax obligations arising from vesting restricted stock units.
Summary
- On September 6, 2024, Juan Graham, the CFO of FibroGen, disposed of 16,050 shares of common stock at a price of $0.39.
- On September 7, 2024, Graham disposed of an additional 1,065 shares of common stock, also at $0.39.
- These transactions were executed to satisfy tax obligations related to the vesting of restricted stock units.
- Following these transactions, Graham directly owns 167,375 shares of FibroGen common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing relates to routine stock disposals for tax purposes, which is a common practice.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The stock disposal by the CFO could have a minor impact on shareholders due to the increased supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 09/06/2024 | Disposal of 16,050 shares of common stock. |
| 09/07/2024 | Disposal of 1,065 shares of common stock. |
| 09/09/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.